Experts agree that the detection of breast cancer in the early stages significantly enhances the chance of recovery. Although most women are aware of this, many still delay in seeking medical care. This study examined the relationship between four personality measures--health locus of control, hopelessness, repression-sensitization, and trait anxiety--and women's delay in approaching a doctor after discovering a lump in the breast. The authors also examined the relationship between delay and behavioral manifestations of body awareness representing the extent of the women's "contact" with their bodies. Five self-report inventories were administered to 62 women who had come for a biopsy as a result of a suspected breast tumor. No significant correlations were found between the personality variables and the time that elapsed before the women approached a doctor. On the other hand, a significant correlation was found between delay in seeking medical care and the measure of the women's "contact" with her body. Possible explanations to account for these results are suggested and their application to planning health education programs is discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/08964289.1991.9935169 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An injectable, self-healing, anti-infective, and anti-inflammatory novel glycyrrhizic acid hydrogel for promoting acute wound healing and regeneration.
Front Bioeng Biotechnol
January 2025
Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Introduction: Bacterial infection, a complex wound microenvironment, and a persistent inflammatory response in acute wounds can result in delayed healing and abnormal scar formation, thereby compromising the normal function and aesthetic appearance of skin tissue. This issue represents one of the most challenging problems in clinical practice. This study aims to develop a hydrogel dressing specifically designed for the treatment of acute wounds, providing immediate and effective protection for the affected areas.
View Article and Find Full Text PDFAspartic acid unveils as antibiofilm agent and tobramycin adjuvant against mucoid and small colony variants of isolates within cystic fibrosis airway mucus.
Biofilm
June 2025
CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
Antibiotics are central to managing airway infections in cystic fibrosis (CF), yet current treatments often fail due to the presence of biofilms, settling down the need for seeking therapies targeting biofilms. This study aimed to investigate the antibiofilm activity of aspartic acid and its potential as an adjuvant to tobramycin against biofilms formed by mucoid and small colony variant (SCV) tobramycin tolerant strain. We assessed the effect of aspartic acid on both surface-attached and suspended biofilms within CF artificial mucus and investigated the synergistic impact of combining it with non-lethal tobramycin concentrations.
View Article and Find Full Text PDFUnderstanding and Improving Pediatric Hearing Care Navigation: A Human-Centered Design Approach.
Otolaryngol Head Neck Surg
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA.
Objective: Explore the experiences of stakeholders within hearing care pathways using a human-centered design process to design a patient navigator (PN) to improve hearing health equity for deaf or hard-of-hearing children.
Study Design: A qualitative, prospective, observational study utilizing the Empathize, Define, and Ideate phases of Human-Centered Design.
Setting: Academic tertiary children's hospital with interviews over Zoom.
From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.
Pharmacoecon Open
January 2025
Department of Health Policy and Medical Technology Research Group, LSE Health, London School of Economics and Political Science, London, UK.
Disparities in access to oncology medicines in European Union (EU) member states can impact patient outcomes profoundly, with availability and timely access varying significantly across and within member states. This paper discusses the intersection of the new European Health Technology Assessment Regulation (HTAR), the provisions of the proposed pharmaceutical legislation and their potential impacts on access to oncology medicines across EU member states. The HTAR, seeking to standardise the clinical evaluation of new medicines, has the potential to streamline the evaluation process but also risks oversimplifying diverse national healthcare needs.
View Article and Find Full Text PDFEarly Identification of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease (COPD).
J Clin Med
January 2025
1st Respiratory Medicine Department, "Sotiria" Chest Hospital, National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece.
Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) have a substantial effect on overall disease management, health system costs, and patient outcomes. However, exacerbations are often underdiagnosed or recognized with great delay due to several factors such as patients' inability to differentiate between acute episodes and symptom fluctuations, delays in seeking medical assistance, and disparities in dyspnea perception. Self-management intervention plans, telehealth and smartphone-based programs provide educational material, counseling, virtual hospitals and telerehabilitation, and help COPD patients to identify exacerbations early.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!